Crescent Biopharma, Inc. (CBIO)

12.49 -0.16 (-1.26%) USD  |  NASDAQ  |  Feb 25, 16:00
More

Crescent Biopharma EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Viridian Therapeutics, Inc. Upgrade
DiaMedica Therapeutics, Inc. Upgrade
Denali Therapeutics, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade